No abstract available
MeSH terms
-
Aged
-
Aged, 80 and over
-
Alendronate / adverse effects*
-
Alendronate / therapeutic use
-
Anti-Inflammatory Agents / adverse effects*
-
Anti-Inflammatory Agents / therapeutic use
-
Diphosphonates / adverse effects*
-
Diphosphonates / therapeutic use
-
Female
-
Follow-Up Studies
-
Humans
-
Image Processing, Computer-Assisted
-
Imaging, Three-Dimensional
-
Long-Term Care
-
Male
-
Mandibular Diseases / chemically induced*
-
Mandibular Diseases / diagnostic imaging
-
Maxillary Diseases / chemically induced*
-
Maxillary Diseases / diagnostic imaging
-
Middle Aged
-
Multiple Myeloma / diagnostic imaging
-
Multiple Myeloma / drug therapy
-
Osteitis Deformans / diagnostic imaging
-
Osteitis Deformans / drug therapy
-
Osteonecrosis / chemically induced*
-
Osteonecrosis / diagnostic imaging
-
Pamidronate
-
Risk Factors
-
Tomography, X-Ray Computed
Substances
-
Anti-Inflammatory Agents
-
Diphosphonates
-
Pamidronate
-
Alendronate